Primary Thyroid Lymphoma: A Rare Diagnosis Treated With Polatuzumab Vedotin

By sjmartinez • November 17, 2024

Sharma R, Orogian A, Garcia-Pacheco R, Trang T, Clarke M, Stull W, Kim S. Primary Thyroid Lymphoma: A Rare Diagnosis Treated With Polatuzumab Vedotin. J Investig Med High Impact Case Rep. 2024 Jan-Dec;12:23247096241299566. doi: 10.1177/23247096241299566. PMID: 39548855; PMCID: PMC11569482.

Tags: chemotherapy for primary thyroid lymphoma, General Internal Medicine, Hematology/Oncology, Kern, Pola-R-CHP, primary diffuse large B-cell lymphoma, Publications, Pulmonary, Critical Care & Sleep Medicine, Resident

William J. Carroll, MD, FACP Appointed Section Chief of Palliative Care and Extensivist Medicine

The UCLA Department of Medicine (DoM) is pleased to announce the appointment of William J. Carroll, MD, FACPas section chief of the UCLA DoM Palliative Care[...]

Joshua N. Khalili, MD Appointed to DoM Chief Wellness Officer

The UCLA Department of Medicine has appointed Joshua N. Khalili, MD to chief wellness officer (CWO) effective April 1. The appointment builds on Dr. Khalili’s outstanding work[...]

Sun M. Yoo, MD, MPH to Depart DoM to Pursue New Leadership Opportunity

The UCLA Department of Medicine (DoM) announces that Sun M. Yoo, MD, MPH, will be departing UCLA Health to assume the role of a founding chief[...]